NL-OMON49830招募中不适用
VASCular no-REact® Graft Against INfection (VASC-REGAIN) Trial - VASC-REGAIN trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Infected prosthetic graft and/or bifurcation, or
- •high risk of infection at graft implantation, or
- •mycotic aneurysm, and
- •no safe alternative available
排除标准
- •Below-knee bypass
研究者
相似试验
已完成
不适用
Vascular No-React Graft Against InfectionVascular InfectionsNCT04031001Catharina Ziekenhuis Eindhoven43
已完成
1 期
A phase I/II study for peptide vaccine of vascular endothelial growth factor receptor-1/2 in patients with progressive or recurrent glioblastoma.GlioblastomaJPRN-UMIN000005545Department of Neurosurgery, Keio University School of Medicine20
进行中（未招募）
1 期
VEGFR 1/2 peptide vaccine for Neurofibromatosis type 2eurofibromatosis type 2 with progressive schwannomaNeurofibromatosis type 2D016518JPRN-jRCTs031180184Toda Masahiro20
招募中
1 期
A phase I/II study for peptide vaccine of vascular endothelial growth factor receptor-1/2 in patients with progressive schwannoma from Neurofibromatosis type 2eurofibromatosis type 2 with progressive schwannomaJPRN-UMIN000023565Keio university school of medicine10
招募中
1 期
VEGFR1/2 peptide vaccine for patients with primary malignant gliomaJPRN-jRCTs031180170Toda Masahiro15